Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma
Authors:
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Choosing the right cell line for renal cell cancer researchMolecular Cancer, 2016
- Roles of mTOR complexes in the kidney: implications for renal disease and transplantationNature Reviews Nephrology, 2016
- Erastin Disrupts Mitochondrial Permeability Transition Pore (mPTP) and Induces Apoptotic Death of Colorectal Cancer CellsPLOS ONE, 2016
- Heme oxygenase-1 accelerates erastin-induced ferroptotic cell deathOncotarget, 2015
- Regulation of Ferroptotic Cancer Cell Death by GPX4Cell, 2014
- Lipid peroxidation and antioxidant system in erythrocytes of patients with renal cell carcinoma.Bulletin of Experimental Biology and Medicine, 2013
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Histological Subtype is an Independent Predictor of Outcome for Patients With Renal Cell CarcinomaJournal of Urology, 2010
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay MethodCancer Research, 2010
- Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cellsCancer Cell, 2003